Published in Biotech Business Week, March 15th, 2004
Pozen reported a net loss of $1.6 million, or $0.06 per share, for the fourth quarter of 2003 compared with a net loss of $5.7 million, or $0.20 per share, for the fourth quarter of 2002. Pozen's net loss was $14.9 million, or $0.52 per common share for 2003, as compared to $24.6 million or $0.87 per common share for 2002.
For the fourth quarter of 2003, Pozen reported revenue of $1.8 million. Revenue for the 12 months ended December 31, 2003, totaled $3.7 million. Pozen did not report any revenue during 2002. Revenue for the fourth quarter and the 12 months...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.